Cosmetic cross-reference Noindex: medium evidence

Calcium Glucoheptonate

CAS 29039-00-7

Calcium Glucoheptonate (CAS 29039-00-7) is a pharmaceutical compound with 0 bioactivity targets and 135 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
135
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE DrugCentral 055904D152D6

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Calcium Glucoheptonate
CAS Number
29039-00-7
UNII
L11651398J
ChEMBL ID
CHEMBL1237066
DrugCentral Struct ID
4433
Source Match
DrugCentral (CAS), FDA GSRS (UNII)
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Calcium Glucoheptonate used for in pharmaceutical contexts?

Calcium Glucoheptonate (CAS 29039-00-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Calcium Glucoheptonate?

Calcium Glucoheptonate has 135 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Lung disorder, Lupus vulgaris, Malaise, Medication error, Memory impairment. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Calcium Glucoheptonate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Calcium Glucoheptonate with EU status "permitted".

What clinical phase is Calcium Glucoheptonate in?

No phase 1-4 clinical development badge is rendered for Calcium Glucoheptonate because the matched compound identifier rows do not contain a max-phase value.